Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-12

Clinical Trial Update: ALL Adult Consortium Trial: Adult ALL Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial in adults with acute lymphoblastic leukemia (ALL) completed for the ALL Adult Consortium; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2025-06-12